Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine

Cancer Research

Volumn 62, Issue 22, 2002, Pages 6456-6461

  Nguyen, Carvell T ^a   Weisenberger, Daniel J ^a   Velicescu, Mihaela ^a   Gonzales, Felicidad A ^a   Lin, Joy C Y ^a   Liang, Gangning ^a   Jones, Peter A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CYTOSINE; HISTONE; HISTONE H3; LYSINE; PROTEIN P14; RNA POLYMERASE;

ACETYLATION; AMINO TERMINAL SEQUENCE; ARTICLE; BLADDER CANCER; CANCER CELL; CHROMATIN; CONTROLLED STUDY; DNA METHYLATION; DNA MODIFICATION; GENE LOCUS; GENE SILENCING; GENE STRUCTURE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ACETYLATION; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; CULTURE TECHNIQUES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; GENE SILENCING; HISTONES; HUMANS; LYSINE; METHYLATION; PRECIPITIN TESTS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF; URINARY BLADDER NEOPLASMS;

EID: 0037112369     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gonzalez-Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T., Beart, R. W., Van Tornout, J. M., and Jones, P. A. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55: 4531-4535, 1995
2. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995
3. Robertson, K. D., and Jones, P. A. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and downregulated by wild-type p53. Mol. Cell. Biol., 18: 6457-6473, 1998
4. Nguyen, C. T., Gonzales, F. A., and Jones, P. A. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: Correlation of accessibility, methylation. MeCP2 binding and acetylation. Nucleic Acids Res., 29: 4598-4606, 2001
5. Litt, M. D., Simpson, M., Gaszner, M., Allis, C. D., and Felsenfeld, G. Correlation between histone lysine methylation and developmental changes at the chicken β-globin locus. Science (Wash. DC), 293: 2453-2455, 2001
6. Nakayama, J., Rice, J. C., Strahl, B. D., Allis, C. D., and Grewal, S. I. Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science (Wash. DC), 292: 110-113, 2001
7. Heard, E., Rougeulle, C., Arnaud, D., Avner, P., Allis, C. D., and Spector, D. L. Methylation of histone H3 at Lys-9 is an early mark on the X chromosome during X inactivation. Cell, 107: 727-738, 2001
8. Boggs, B. A., Cheung, P., Heard, E., Spector, D. L., Chinault, A. C., and Allis, C. D. Differentially methylated forms of histone H3 show unique association patterns with inactive human X chromosomes. Nat. Genet., 30: 73-76, 2002
9. Peters, A. H., Mermoud, J. E., O’Carroll, D., Pagani, M., Schweizer, D., Brockdorff, N., and Jenuwein, T. Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin. Nat. Genet., 30: 77-80, 2002
10. Maison, C., Bailly, D., Peters, A. H., Quivy, J. P., Roche, D., Taddei, A., Lachner, M., Jenuwein, T., and Almouzni, G. Higher-order structure in pericentric heterochromatin involves a distinct pattern of histone modification and an RNA component. Nat. Genet., 30: 329-334, 2002
11. Nan, X., Ng, H. H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., and Bird, A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (Lond.), 393: 386-389, 1998
12. Jones, P. L., Veenstra, G. J., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., and Wolffe, A. P. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet., 19: 187-191, 1998
13. Tamaru, H., and Selker, E. U. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature (Lond.), 414: 277-283, 2001
14. Liang, G., Chan, M. F., Tomigahara, Y., Tsai, Y. C., Gonzales, F. A., Li, E., Laird, P. W., and Jones, P. A. Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol. Cell. Biol., 22: 480-491, 2002
15. Bender, C. M., Pao, M. M., and Jones, P. A. Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res., 58: 95-101, 1998
16. Bender, C. M., Gonzalgo, M. L., Gonzales, F. A., Nguyen, C. T., Robertson, K. D., and Jones, P. A. Roles of cell division and gene transcription in the methylation of CpG islands. Mol. Cell. Biol., 19: 6690-6698, 1999
17. Lewis, J. D., Meehan, R. R., Henzel, W. J., Maurer-Fogy, I., Jeppesen, P., Klein, F., and Bird, A. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell, 69: 905-914, 1992
18. Nguyen, C., Liang, G., Nguyen, T. T., Tsao-Wei, D., Groshen, S., Lubbert, M., Zhou, J. H., Benedict, W. F., and Jones. P. A. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. J. Natl. Cancer Inst. (Bethesda), 93: 1465-1472, 2001
19. Jones, P. A. The DNA methylation paradox. Trends Genet., 15: 34-37, 1999
20. Fuks, F., Burgers, W. A., Brehm, A., Hughes-Davies, L., and Kouzarides, T. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat. Genet., 24: 88-91, 2000
21. Rountree, M. R., Bachman, K. E., and Baylin, S. B. DNMT1 binds HDAC2 and a new co-repressor. DMAP1, to form a complex at replication foci. Nat. Genet., 25: 269-277, 2000
22. Robertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L., and Wolffe, A. P. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat. Genet., 25: 338-342, 2000
23. El-Osta, A., Kantharidis, P., Zalcberg, J. R., and Wolffe, A. P. Precipitous release of methyl-CpG binding protein 2 and histone deacetylase I from the methylated human multidrug resistance gene (MDRI) on activation. Mol. Cell Biol., 22: 1844-1857, 2002
24. Takebayashi, S., Nakao, M., Fujita, N., Sado, T., Tanaka, M., Taguchi, H., and Okumura, K. 5-Aza-2′-deoxycytidine induces histone hyperacetylation of mouse centromeric heterochromatin by a mechanism independent of DNA demethylation. Biochem. Biophys. Res. Commun., 288: 921-926, 2001
25. Ng, H. H., Zhang, Y., Hendrich, B., Johnson, C. A., Turner, B. M., Erdjument-Bromage, H., Tempst, P., Reinberg, D., and Bird, A. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat. Genet., 23: 58-61, 1999